Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations

Infection and Immunity

Volumn 75, Issue 7, 2007, Pages 3462-3469

  Taylor, Jennifer M ^a   Ziman, Melanie E ^a   Fong, Julie ^a   Solnick, Jay V ^a   Vajdy, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ADMINISTRATION ROUTE; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNITY, MUCOSAL; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; STOMACH; TIME FACTORS;

EID: 34447251541     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01470-06     Document Type: Article

References (44)

1. Akhiani, A. A. 2005. The role of type-specific antibodies in colonization and infection by Helicobacter pylori. Curr. Opin. Infect. Dis. 18:223-227.
2. Akhiani, A. A., J. Pappo, Z. Kabok, K. Schon, W. Gao, L. E. Franzen, and N. Lycke. 2002. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol. 169:6977-6984.
3. Akhiani, A. A., K. Schon, L. E. Franzen, J. Pappo, and N. Lycke. 2004. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J. Immunol. 172:5024-5033.
4. Akhiani, A. A., A. Stensson, K. Schon, and N. Y. Lycke. 2005. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J. Immunol. 174:8144-8153.
5. Del Giudice, G., A. Covacci, J. L. Telford, C. Montecucco, and R. Rappuoli. 2001. The design of vaccines against Helicobacter pylori and their development. Annu. Rev. Immunol. 19:523-563.
6. Del Giudice, G., and P. Michetti. 2004. Inflammation, immunity and vaccines for Helicobacter pylori. Helicobacter 9(Suppl. 1):23-28.
7. Dietrich, G., M. Griot-Wenk, I. C. Metcalfe, A. B. Lang, and J. F. Viret. 2003. Experience with registered mucosal vaccines. Vaccine 21:678-683.
8. el-Madhun, A. S., R. J. Cox, A. Soreide, J. Olofsson, and L. R. Haaheim. 1998. Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination. J. Infect. Dis. 178:933-939.
9. Garhart, C. A., J. G. Nedrud, F. P. Heinzel, N. E. Sigmund, and S. J. Czinn. 2003. Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect. Immun. 71:3628-3633.
10. Garhart, C. A., R. W. Redline, J. G. Nedrud, and S. J. Czinn. 2002. Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect. Immun. 70: 3529-3538.
11. Goto, T., A. Nishizono, T. Fujioka, J. Ikewaki, K. Mifune, and M. Nasu. 1999. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice. Infect. Immun. 67:2531-2539.
12. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77:11708-11717.
13. Guy, B., C. Hessler, S. Fourage, J. Haensler, E. Vialon-Lafay, B. Rokbi, and M. J. Millet. 1998. Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 16:850-856.
14. Herremans, T. M., J. H. Reimerink, A. M. Buisman, T. G. Kimman, and M. P. Koopmans. 1999. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J. Immunol. 162:5011-5018.
15. Jeremy, A. H., Y. Du, M. F. Dixon, P. A. Robinson, and J. E. Crabtree. 2006. Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination. Microbes Infect. 8:340-346.
16. Kao, J. Y., S. Rathinavelu, K. A. Eaton, L. Bai, Y. Zavros, M. Takami, A. Pierzchala, and J. L. Merchant. 2006. Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense. Am. J. Physiol. Gastrointest. Liver Physiol. 291:G73-G81.
17. Kaul, D., and P. L. Ogra. 1998. Mucosal responses to parenteral and mucosal vaccines. Dev. Biol. Stand. 95:141-146.
18. Keenan, J. I., S. G. Rijpkema, Z. Durrani, and J. A. Roake. 2003. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens. FEMS Immunol. Med. Microbiol. 36:199-205.
19. Kew, O. M., R. W. Sutter, E. M. de Gourville, W. R. Dowdle, and M. A. Pallansch. 2005. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59:587-635.
20. Kleanthous, H., G. A. Myers, K. M. Georgakopoulos, T. J. Tibbitts, J. W. Ingrassia, H. L. Gray, R. Ding, Z. Z. Zhang, W. Lei, R. Nichols, C. K. Lee, T. H. Ermak, and T. P. Monath. 1998. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect. Immun. 66:2879-2886.
21. Kleanthous, H., T. J. Tibbitts, H. L. Gray, G. A. Myers, C. K. Lee, T. H. Ermak, and T. P. Monath. 2001. Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent. Vaccine 19:4883-4895.
22. Lee, C. K., K. Soike, P. Giannasca, J. Hill, R. Weltzin, H. Kleanthous, J. Blanchard, and T. P. Monath. 1999. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine 17:3072-3082.
23. Lycke, N., and J. Holmgren. 1986. Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin. Scand. J. Immunol. 23:611-616.
24. Marchetti, M., M. Rossi, V. Giannelli, M. M. Giuliani, M. Pizza, S. Censini, A. Covacci, P. Massari, C. Pagliaccia, R. Manetti, J. L. Telford, G. Douce, G. Dougan, R. Rappuoli, and P. Ghiara. 1998. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 16:33-37.
25. McCluskie, M. J., R. D. Weeratna, P. J. Payette, and H. L. Davis. 2002. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. FEMS Immunol. Med. Microbiol. 32:179-185.
26. Michetti, P., and A. M. Svennerholm. 2003. Helicobacter pylori-inflammation, immunity and vaccines. Helicobacter 8(Suppl. 1):31-35.
27. Myers, G. A., T. H. Ermak, K. Georgakopoulos, T. Tibbitts, J. Ingrassia, H. Gray, H. Kleanthous, C. K. Lee, and T. P. Monath. 1999. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection. Vaccine 17:1394-1403.
28. Navaglia, F., D. Basso, C. F. Zambon, E. Ponzano, L. Caenazzo, N. Gallo, A. Falda, C. Belluco, P. Fogar, E. Greco, F. Di Mario, M. Rugge, and M. Plebani. 2005. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals. J. Med. Genet. 42:503-510.
29. Nystrom, J., S. Raghavan, and A. M. Svennerholm. 2006. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect. 8:442-449.
30. Oien, N. L., R. J. Brideau, E. E. Walsh, and M. W. Wathen. 1994. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine 12:731-735.
31. Parsonnet, J. 2003. What is the Helicobacter pylori global reinfection rate? Can. J. Gastroenterol. 17(Suppl. B):46B-48B.
32. Peek, R. M., Jr., and M. J. Blaser. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2:28-37.
33. Radcliff, F. J., M. Chen, and A. Lee. 1996. Protective immunization against Helicobacter stimulates long-term immunity. Vaccine 14:780-784.
34. Radcliff, F. J., S. L. Hazell, T. Kolesnikow, C. Doidge, and A. Lee. 1997. Catalase, a novel antigen for Helicobacter pylori vaccination. Infect. Immun. 65:4668-4674.
35. Shi, T., W. Z. Liu, F. Gao, G. Y. Shi, and S. D. Xiao. 2005. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection. Helicobacter 10:71-79.
36. Solnick, J. V., D. R. Canfield, L. M. Hansen, and S. Z. Torabian. 2000. Immunization with recombinant Helicobacter pylori urease in specific-pathogen-free rhesus monkeys (Macaca mulatta). Infect. Immun. 68:2560-2565.
37. Suerbaum, S., and P. Michetti. 2002. Helicobacter pylori infection. N. Engl. J. Med. 347:1175-1186.
38. Sutton, P., S. J. Danon, M. Walker, L. J. Thompson, J. Wilson, T. Kosaka, and A. Lee. 2001. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut 49:467-473.
39. Vajdy, M., M. Singh, J. Kazzaz, E. Soenawan, M. Ugozzoli, F. Zhou, I. Srivastava, Q. Bin, S. Barnett, J. Donnelly, P. Luciw, L. Adamson, D. Montefiori, and D. T. O'Hagan. 2004. Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intranasal and parenteral immunizations. AIDS Res. Hum. Retrovir. 20:1269-1281.
40. Vajdy, M., M. Singh, M. Ugozzoli, M. Briones, E. Soenawan, L. Cuadra, J. Kazzaz, P. Ruggiero, S. Peppoloni, F. Norelli, G. del Giudice, and D. O'Hagan. 2003. Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations. Immunology 110:86-94.
41. van der Ende, A., R. W. van der Hulst, J. Dankert, and G. N. Tytgat. 1997. Reinfection versus recrudescence in Helicobacter pylori infection. Aliment. Pharmacol. Ther. 11(Suppl. 1):55-61.
42. Walker, R. I. 1994. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12:387-400.
43. Weltzin, R., B. Guy, W. D. Thomas, Jr., P. J. Giannasca, and T. P. Monath. 2000. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect. Immun. 68:2775-2782.
44. Yamamoto, T., M. Kita, T. Ohno, Y. Iwakura, K. Sekikawa, and J. Imanishi. 2004. Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection. Microbiol. Immunol. 48:647-654.